Search results

The umbilical cord blood has been used as a source of stem cells in the treatment of several diseases, especially haematologic malignancies. Since the first transplant performed with these cells in the 1980s, numerous transplants have been carried out, which demonstrates that the umbilical cord blood represents an alternative to other sources of stem cells. Clinical trials performed with these umbilical cord blood stem cells reveal promising results by foreseeing an expansion of its use to several diseases, particularly to degenerative disorders. Taking into account that the cryopreservation procedure doesn’t change the feasibility of these cells, they can be stored for long periods of time and only used when needed. By getting acquainted with the potential of the umbilical cord blood stem cells, public and private stem cells and cryop...